EUCALIA

EUCALIA EBITDA per Employee

The EBITDA per Employee of EUCALIA (286A.T) as of Oct 28, 2026 is 2.91 M JPY. In the previous year, EBITDA per Employee was 2.82 M JPY — a change of 3.16% (higher).

EBITDA per Employee

2.91 MJPY

YoY

3.16%

Last updated:

EBITDA per Employee of EUCALIA is 2025 2.91 M JPY. EBITDA per Employee of EUCALIA was 2024 2.82 M JPY. It decreases by 3.16% higher compared to the previous year.

The EUCALIA EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2022
1.07 M JPY
Jan 1, 2023
2.34 M JPY
Jan 1, 2024
2.82 M JPY
Jan 1, 2025
2.91 M JPY
The EUCALIA EBITDA per Employee history
YEAREBITDA per EmployeeYoY
2.91 MJPY+3.16%
2.82 MJPY+20.69%
2.34 MJPY+119.47%
1.07 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EUCALIA Stock analysis

What does EUCALIA do? EUCALIA Inc generates revenue through three core business segments. The Medical Management Comprehensive Support Business offers management consulting, personnel recruitment, DX support, and fundraising for medical corporations. The Senior Related Business provides nursing care facility operations, admission consultation, and facility introduction services. The Highly Controlled Medical Device Business sells contact lenses and supplies pharmaceutical companies with treatment progress data analysis and sales activity support. Subsidiaries contribute through venture investment, brain checkup services, and real estate transactions. Pharmaceutical companies purchase treatment progress data analysis and sales activity support services. Medical corporations utilize management consulting, recruitment, DX, and fundraising support. Nursing care facility operators and potential residents engage with senior care services. Venture investments and real estate transactions are handled by subsidiaries, supporting the company's broader financial ecosystem. The company's revenue streams are diversified across healthcare support, senior care services, and medical device manufacturing. Medical corporations, pharmaceutical firms, and nursing care facility stakeholders form the primary customer base. Subsidiary activities in venture investment and real estate complement the core business model without direct revenue generation from these segments. EUCALIA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EUCALIA stock

EBITDA per Employee of EUCALIA is 2.91 M JPY in 2025.

EBITDA per Employee of EUCALIA changed from 2.82 M JPY to 2.91 M JPY, representing a 3.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee EUCALIA since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's EUCALIA historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — EUCALIA

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — EUCALIA